FDA Orders Pfizer to Pull Viagra Ads

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

WASHINGTON, D.C. The federal government has told Pfizer to pull its ads that promised better sex for men taking Viagra because they “failed to disclose known risks associated with the drug,” according to a letter from the Food and Drug Administration.

Spots such as “Wild Thing,” via Interpublic Group’s McCann Erickson in New York (which won the estimated $110 million account in June), “omit the indication for the drug (namely, treatment of erectile dysfunction) and fail to provide information relating to the major side effects and contraindications of the drug, as required,” Christine Hemler Smith, FDA regulatory review officer, informed Pfizer in a letter posted on the agency’s Web site.

In



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in